[ALA] YoY Quarter Result on 31-Mar-2020 [#Q3]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q3]
Profit Trend
QoQ- 85.48%
YoY- 67.71%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 13 137 319 106 198 43 1,875 -56.31%
PBT -3,141 -2,335 -1,650 -1,446 -3,925 -2,276 -501 35.77%
Tax 0 0 0 -328 463 -373 340 -
NP -3,141 -2,335 -1,650 -1,118 -3,462 -1,903 -161 64.03%
Tax Rate - - - - - - - -
Total Cost 3,154 2,472 1,969 1,224 3,660 1,946 2,036 7.56%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -23,877.58 -1,709.48 -517.19 -1,053.37 -1,748.22 -4,437.93 -8.58 274.81%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.00 -0.00 -0.00 -0.01 -0.03 -0.04 -0.00 -
EPS Diluted -0.00 -0.00 -0.00 -0.01 -0.03 -0.04 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.